-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Mersana Therapeutics, Inc. annual Depreciation history and growth rate from 2015 to 2023.
- Mersana Therapeutics, Inc. annual Depreciation for 2023 was $1.5M, a 66.7% increase from 2022.
- Mersana Therapeutics, Inc. annual Depreciation for 2022 was $900K, unchanged from 2021.
- Mersana Therapeutics, Inc. annual Depreciation for 2021 was $900K, a 10% decline from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)